Health-Related Quality of Life Outcomes of Omeprazole versus Ranitidine in Poorly Responsive Symptomatic Gastroesophageal Reflux Disease

Publisher： Karger

E-ISSN： 1421-9875|16|5|284-291

ISSN： 0257-2753

Source： Digestive Diseases, Vol.16, Iss.5, 1999-01, pp. : 284-291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease

By De Vries Durk R. Van Herwaarden Margot A. Baron Astrid Smout André J. P. M. Samsom Melvin

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 8, 2007-01 ,pp. : 951-956

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Pantoprazole versus Ranitidine in the Treatment of Patients with Symptomatic Gastroesophageal Reflux Disease

Digestion, Vol. 70, Iss. 1, 2004-09 ,pp. : 61-69

Karger

Access to resources Recommend Favorite

On-Demand Therapy with Rabeprazole in Nonerosive and Erosive Gastroesophageal Reflux Disease in Clinical Practice: Effectiveness, Health-Related Quality of Life, and Patient Satisfaction

By Ponce Julio Argüello Lidia Bastida Guillermo Ponce Marta Ortiz Vicente Garrigues Vicente

Digestive Diseases and Sciences, Vol. 49, Iss. 6, 2004-06 ,pp. : 931-936

Springer Publishing Company

Access to resources Recommend Favorite

Neuroepidemiology, Vol. 17, Iss. 3, 1998-06 ,pp. : 116-120

Karger

Access to resources Recommend Favorite

Efficacy of Rabeprazole in the Treatment of Symptomatic Gastroesophageal Reflux Disease

By Kahrilas Peter Miner Philip Johanson John Mao Lian Jokubaitis Leonard Sloan Sheldon

Digestive Diseases and Sciences, Vol. 50, Iss. 11, 2005-11 ,pp. : 2009-2018

Springer Publishing Company

Access to resources Recommend Favorite